StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.16−0.01 (-8.72%)

Close on Nov 20, 2026Market cap $708.38KP/E –Yield –

Oragenics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Oragenics's free cash flow for the twelve months ending Dec 31, 2022 was -$15.36M. For fiscal 2022 it was -$15.36M. The highest annual figure on record is -$5.22M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$15.36M–
FY2021Dec 31, 2021-$13.51M–
FY2019Dec 31, 2019-$13.04M–
FY2018Dec 31, 2018-$9.20M–
FY2016Dec 31, 2016-$7.10M–
FY2015Dec 31, 2015-$5.29M–
FY2014Dec 31, 2014-$5.67M–
FY2013Dec 31, 2013-$6.78M–
FY2012Dec 31, 2012-$5.22M–
FY2010Dec 31, 2010-$6.54M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-$2.44M–
Q3 FY2022Sep 30, 2022-$3.81M–
Q2 FY2022Jun 30, 2022-$3.38M–
Q1 FY2022Mar 31, 2022-$5.72M–
Q4 FY2021Dec 31, 2021-$2.50M–
Q4 FY2019Dec 31, 2019-$3.95M–
Q3 FY2019Sep 30, 2019-$3.38M–
Q4 FY2018Dec 31, 2018-$3.04M–
Q4 FY2016Dec 31, 2016-$1.96M–

More Oragenics figures

See a number that looks wrong?